Amir Iravani, a nuclear medicine physician-scientist specializing in molecular imaging and targeted radiopharmaceutical therapies for patients with cancer, has joined UCLA Health where he will serve as director of the Theranostics Program and vice chair of clinical research in the department of nuclear medicine and theranostics.
Change swept through executive offices at cancer centers in recent weeks, shifting top leadership at the University of Texas MD Anderson Cancer Center, Duke Cancer Institute, and the University of Florida.
